BackNovozymes A/S Overview
Novozymes A/S

Novozymes A/S P/E Ratio

Latest P/E ratio for Novozymes A/S: 40.92 — see history and peer comparisons.

Get informed when a big investor buys or sells

+ Follow

P/E Ratio

40.92

P/E Ratio

40.92

The P/E ratio compares a company's stock price to its earnings per share. A lower P/E ratio may indicate that the stock is undervalued.

P/E Ratio (Comparison Companies)

Loading

P/E Ratio History

Loading

P/E Ratio Comparison

Loading

Novozymes A/S (NVZMF) FAQ

The latest P/E ratio for NVZMF is 40.92. That is above the sector sector average of 22.75. Investors often review this figure alongside Novozymes A/S's historical trend and sector peers before judging valuation or financial health.

Against its sector companies, NVZMF currently prints 40.92 for P/E ratio, while the sector average sits near 22.75. That is roughly 79.9% above the sector mean. Large gaps often invite a closer look at Novozymes A/S's growth, margins, and balance sheet.

A P/E ratio of 40.92 for Novozymes A/S is not 'good' or 'bad' on its own. Compare it with the peer average (22.75) and with NVZMF's multi-year chart on this page. Persistently elevated multiples need growth or quality to justify them; depressed multiples need a catalyst or evidence the business is misunderstood.

After noting NVZMF's P/E ratio (40.92), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.